FROECHLICH, GUENDALINA
 Distribuzione geografica
Continente #
EU - Europa 638
NA - Nord America 290
AS - Asia 190
SA - Sud America 27
AF - Africa 12
Totale 1.157
Nazione #
US - Stati Uniti d'America 278
IT - Italia 245
RU - Federazione Russa 243
SG - Singapore 79
HK - Hong Kong 59
GB - Regno Unito 46
DE - Germania 33
NL - Olanda 28
BR - Brasile 26
CN - Cina 25
IN - India 17
FR - Francia 15
CA - Canada 11
FI - Finlandia 11
CI - Costa d'Avorio 10
SE - Svezia 5
AT - Austria 3
ES - Italia 3
KR - Corea 3
BD - Bangladesh 2
JP - Giappone 2
PL - Polonia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
MX - Messico 1
RO - Romania 1
RS - Serbia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.157
Città #
Naples 106
Hong Kong 59
Moscow 59
Singapore 48
Chandler 45
Santa Clara 37
Amsterdam 26
Ashburn 26
Millbury 13
San Paolo Bel Sito 12
Lawrence 11
Napoli 11
Frankfurt am Main 10
Seattle 8
Kochi 7
Los Angeles 7
Marano 7
Pune 7
Helsinki 6
Rome 6
Boston 5
Des Moines 5
Falkenstein 5
Formia 5
Milan 5
The Dalles 5
Beijing 4
Düsseldorf 4
Ercolano 4
Toronto 4
Wilmington 4
Afragola 3
Arezzo 3
Casalnuovo di Napoli 3
Hefei 3
Lappeenranta 3
London 3
Nuremberg 3
Ottawa 3
Portsmouth 3
San Vitaliano 3
Seoul 3
Trentola-Ducenta 3
Washington 3
Arpino 2
Campi Bisenzio 2
Capaccio 2
Casavatore 2
Chicago 2
Ischia 2
Jiaxing 2
Marano di Napoli 2
Montreal 2
Munich 2
Nanjing 2
Reggio Emilia 2
Roubaix 2
São Paulo 2
Turku 2
Acerra 1
Alexandria 1
Alfenas 1
Alpinópolis 1
Alvorada 1
Amambai 1
Aprilia 1
Araraquara 1
Arcos 1
Atlanta 1
Augusta 1
Belgrade 1
Belo Horizonte 1
Belém 1
Bexley 1
Bilbao 1
Bologna 1
Brasília 1
Brussels 1
Buffalo 1
Campinas 1
Campos dos Goytacazes 1
Catanzaro 1
Changji 1
Charlotte 1
Chennai 1
Chongqing 1
Cristópolis 1
Cubatão 1
Dharmapuri 1
Dubai 1
Fairburn 1
Fairfield 1
Fisciano 1
Gdansk 1
Gravatá 1
Guanambi 1
Hebei 1
Istanbul 1
Jinan 1
Johannesburg 1
Totale 671
Nome #
Integrity of the antiviral STING-mediated DNA sensing in tumor cells is required to sustain the immunotherapeutic efficacy of herpes simplex oncolytic virus 116
Generation of a novel mesothelin-targeted oncolytic herpes virus and implemented strategies for manufacturing 107
Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus 93
Generation of a retargeted oncolytic herpes virus encoding adenosine deaminase for tumor adenosine clearance 81
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 77
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 75
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment 74
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 71
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 70
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 63
Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis 63
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 60
Immunomodulatory mabs as tools to investigate on cis-interaction of pd-1/pd-l1 on tumor cells and to set up methods for early screening of safe and potent combinatorial treatments 57
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 54
Prime and pull of Tcell responses against cancer-exogenous antigens is effective against CPI-resistant tumors 44
Peptide nucleic acid-mediated circularization of target RNA as tool to inhibit translation 33
null 33
The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties 32
Totale 1.203
Categoria #
all - tutte 4.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 4 0 0 0 0 5 0 4 4 0
2021/2022141 2 3 10 4 7 7 26 10 16 15 18 23
2022/2023131 12 6 2 6 23 16 1 10 20 25 10 0
2023/2024161 4 16 26 18 7 24 1 14 2 24 20 5
2024/2025732 42 20 16 11 28 62 66 42 45 87 274 39
Totale 1.203